Trial
NCT05776875
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
Genentech, Inc.
Condition
Hepatocellular Carcinoma
Intervention
Atezolizumab Injection
Why stopped
Low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-15